The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: a systematic review of trials

R Felten, F Scher, J Sibilia, JE Gottenberg… - Autoimmunity Reviews, 2019 - Elsevier
To date, no immunomodulatory drug has proved efficacious in primary Sjögren's syndrome
(pSS). In pSS, difficulties in drug efficacy assessment is related to the large spectrum of …
被引用次数：48 相关文章
[PDF] hal.science

[PDF][PDF] The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials

R Felten, F Scher, J Sibilia, JE Gottenberg… - Autoimmunity …, 2019 - hal.science
To date, no immunomodulatory drug has proved efficacious in primary Sjögren's syndrome
(pSS). In pSS, difficulties in drug efficacy assessment is related to the large spectrum of …

The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials.

R Felten, F Scher, J Sibilia, JE Gottenberg… - Autoimmunity …, 2019 - europepmc.org
To date, no immunomodulatory drug has proved efficacious in primary Sjögren's syndrome
(pSS). In pSS, difficulties in drug efficacy assessment is related to the large spectrum of …

The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials

R Felten, F Scher, J Sibilia… - Autoimmunity …, 2019 - pubmed.ncbi.nlm.nih.gov
To date, no immunomodulatory drug has proved efficacious in primary Sjögren's syndrome
(pSS). In pSS, difficulties in drug efficacy assessment is related to the large spectrum of …
[PDF] hal.science

[PDF][PDF] The pipeline of targeted therapies under clinical development for primary Sjögren's syndrome: A systematic review of trials

R Felten, F Scher, J Sibilia, JE Gottenberg, L Arnaud - 2019 - hal.science
To date, no immunomodulatory drug has proved efficacious in primary Sjögren's syndrome
(pSS). In pSS, difficulties in drug efficacy assessment is related to the large spectrum of …